FDA is departing from long-standing procedures to deal with public health crises, and this may foreshadow problems for COVID-19 vaccines
- Written by Ana Santos Rutschman, Assistant Professor of Law, Saint Louis University

On the eve of the Republican National Convention, Food and Drug Administration Commissioner Dr. Stephen Hahn announced that the FDA had issued emergency use authorization for investigational convalescent plasma...